National Institutes of Health
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing September 7, 2028.
Overview
This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways…